HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Olivier Sitbon Selected Research

Vascular Remodeling

10/2021TORREY, a Phase 2 study to evaluate the efficacy and safety of inhaled seralutinib for the treatment of pulmonary arterial hypertension.
9/2009Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension.
12/2005Idiopathic pulmonary hypertension: what did we learn from genes?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Olivier Sitbon Research Topics

Disease

127Pulmonary Arterial Hypertension
10/2024 - 03/2002
45Pulmonary Hypertension
10/2024 - 03/2002
14Familial Primary Pulmonary Hypertension
01/2020 - 02/2002
12Disease Progression
04/2024 - 06/2004
10Connective Tissue Diseases (Connective Tissue Disease)
01/2020 - 07/2006
8Hypertension (High Blood Pressure)
10/2023 - 01/2006
8Pulmonary Veno-Occlusive Disease (Veno Occlusive Disease, Pulmonary)
01/2021 - 03/2002
7Hypoxia (Hypoxemia)
10/2024 - 06/2009
7Heart Failure
12/2023 - 08/2002
7HIV Infections (HIV Infection)
10/2013 - 12/2004
6Congenital Heart Defects (Congenital Heart Defect)
01/2019 - 06/2005
5Interstitial Lung Diseases (Interstitial Lung Disease)
10/2023 - 08/2011
5Infections
01/2023 - 11/2008
5Headache (Headaches)
01/2023 - 10/2008
4Portal Hypertension
04/2024 - 11/2008
4Nausea
01/2023 - 10/2008
4Neoplasms (Cancer)
10/2021 - 07/2010
4Systemic Scleroderma (Systemic Sclerosis)
08/2016 - 03/2010
3Dyspnea (Shortness of Breath)
05/2024 - 08/2002
3Mixed Connective Tissue Disease (MCTD)
10/2023 - 07/2006
3Diarrhea
01/2023 - 12/2015
3Vascular Remodeling
10/2021 - 12/2005
3Pleural Effusion (Pleural Effusions)
10/2020 - 03/2002
3Sarcoidosis (Schaumann Disease)
10/2017 - 11/2015
2Hepatopulmonary Syndrome
04/2024 - 07/2016
2Fibrosis (Cirrhosis)
04/2024 - 01/2013
2Right Ventricular Dysfunction
01/2023 - 09/2014
2Syncope (Fainting)
10/2022 - 08/2002
2Inflammation (Inflammations)
01/2021 - 10/2013
2Rare Diseases (Rare Disease)
01/2019 - 09/2015
2Eisenmenger Complex (Eisenmenger's Syndrome)
05/2017 - 04/2017
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2016 - 05/2012
2Pain (Aches)
12/2015 - 10/2008
2Hereditary Hemorrhagic Telangiectasia
04/2010 - 12/2005
2Lymphadenopathy
01/2010 - 03/2002
2Pulmonary Edema
08/2009 - 07/2008
1Arthritis (Polyarthritis)
10/2023

Drug/Important Bio-Agent (IBA)

32Epoprostenol (Prostacyclin)FDA LinkGeneric
01/2023 - 02/2002
17Endothelin Receptor AntagonistsIBA
01/2020 - 07/2003
14selexipagIBA
01/2023 - 12/2015
13macitentanIBA
01/2022 - 08/2013
12Bosentan (Tracleer)FDA Link
01/2013 - 07/2003
9Vasodilator Agents (Vasodilators)IBA
01/2019 - 02/2002
6Biomarkers (Surrogate Marker)IBA
01/2023 - 10/2012
6ProstaglandinsIBA
01/2022 - 09/2002
6Endothelins (Endothelin)IBA
12/2012 - 06/2004
5pro-brain natriuretic peptide (1-76)IBA
10/2023 - 01/2017
5Epoprostenol ReceptorsIBA
01/2022 - 12/2015
5Dasatinib (BMS 354825)FDA Link
10/2020 - 05/2012
5Phosphodiesterase 5 InhibitorsIBA
01/2020 - 09/2009
5Sildenafil Citrate (Viagra)FDA Link
01/2014 - 10/2008
5Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2013 - 06/2002
4riociguatIBA
06/2023 - 12/2015
4Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
12/2016 - 06/2008
4Calcium Channel Blockers (Blockers, Calcium Channel)IBA
01/2013 - 06/2005
3Brain Natriuretic Peptide (Natrecor)FDA Link
01/2023 - 01/2019
3ProteomeIBA
01/2022 - 01/2017
3Tadalafil (Cialis)FDA Link
10/2021 - 09/2009
3Adrenal Cortex Hormones (Corticosteroids)IBA
10/2021 - 10/2014
3Mitomycin (Mitomycin-C)FDA LinkGeneric
01/2021 - 09/2015
3Proteins (Proteins, Gene)FDA Link
01/2021 - 12/2005
3treprostinilFDA Link
01/2020 - 01/2007
3InterferonsIBA
01/2016 - 12/2014
3Appetite Depressants (Anorectics)IBA
10/2011 - 11/2008
2Clostridium perfringens epsilon-toxinIBA
07/2023 - 11/2017
2CytokinesIBA
01/2023 - 03/2014
2Phosphotransferases (Kinase)IBA
10/2021 - 01/2018
2Carbon MonoxideIBA
01/2021 - 01/2010
2MonocrotalineIBA
01/2021 - 11/2010
2bosutinibIBA
10/2020 - 11/2016
2Imatinib Mesylate (Gleevec)FDA Link
10/2020 - 01/2016
2Type II Bone Morphogenetic Protein Receptors (Bone Morphogenetic Protein Receptor Type II)IBA
01/2018 - 02/2016
2Prostaglandins IIBA
04/2016 - 01/2016
2DiureticsIBA
07/2013 - 06/2009
2FenfluramineIBA
11/2012 - 06/2005
2Immunosuppressive Agents (Immunosuppressants)IBA
02/2008 - 07/2006
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2008 - 07/2006
2beraprostIBA
06/2004 - 05/2002
1Long Noncoding RNAIBA
10/2024
1Histone-Lysine N-MethyltransferaseIBA
10/2024
1Bortezomib (Velcade)FDA Link
05/2024
1carfilzomibIBA
05/2024
1Proteasome InhibitorsIBA
05/2024
1Growth Differentiation Factor 2IBA
04/2024
1ACE-011IBA
01/2024
1AntibodiesIBA
10/2023

Therapy/Procedure

67Therapeutics
03/2024 - 03/2002
8Transplantation
12/2023 - 03/2006
7Liver Transplantation
01/2022 - 09/2014
7Lung Transplantation
01/2022 - 09/2002
6Drug Therapy (Chemotherapy)
07/2023 - 01/2015
5Endarterectomy (Thromboendarterectomy)
01/2021 - 04/2007
4Contraindications
01/2020 - 01/2006
4Highly Active Antiretroviral Therapy (HAART)
10/2013 - 09/2008
3Heart-Lung Transplantation
12/2023 - 10/2014
3Aftercare (After-Treatment)
10/2021 - 07/2008
2Intravenous Infusions
04/2016 - 05/2002
1Ligation
04/2024
1Surgical Portasystemic Shunt (Portosystemic Shunt)
01/2024
1Critical Care (Surgical Intensive Care)
12/2023